Regulatory alignment for the next generation of health tech companies
Menu
Key Benefit
We bridge the gap between your health tech product design and your users' payment and workflow requirements.
Proof Points
Currently, the health tech market experiences an 80–90% failure rate.
Half of this failure is due to nonobservance of regulatory standards — Leading to billions in lost revenue.
We believe
From a regulatory perspective, the current US healthcare market has never been more complex yet open to more opportunity for the use of health tech.
Partnering with Elevation’s top national policy and reimbursement experts is key to seizing this opportunity and ensuring you avoid regulatory misalignment.
Client snapshot
Market leaders choose Elevation to gain a regulatory and reimbursement edge:
Top virtual care platform
Designed reimbursement algorithms matching tech capabilities
Top 10 nationally recognized EHR company
Drove optimal product capabilities against regulatory requirements
Fortune 50 tech firm
Audited state-based reimbursement potentials for new products
Top 5 health information exchange
Forecasted business impact from emerging regulation
Results
- Doubled company value from $160M to $320M, subsequently positioning them to sell 20 months after their IPO for $644M
- Redesigned business's data exchange policies to avoid >$10M in fines
- Increased reimbursables by 200% by redesigning workflow and billing algorithms
- Saved R&D and marketing time, money, and resources with FDA approval strategy
Our team
Multiple former program directors and regulation authors
Current CMS reimbursement and data exchange policy influencer
Former regulation authors and top legal advisor to tech industry on FDA processes
Former funding director and federal data scientist shaping NIH data policies
Former legislative assistant on Health Information Technology Policy
Various HL7 leads for data exchange policy and data standards
Multiple national workgroup chairs and leads on industry forecasting and policy positioning
